Tagged with P

Indonesia Mada Shinta Dewi, country manager at Mundipharma Indonesia, explains the unique business model of Mundipharma in Indonesia, collaboration with the local business community, and the benefits that the company’s consumer health medicines and ethical business line can bring to patients. Could you please explain to our international audience how the…

Colombia Héctor Robles, General Manager of Laboratorios Sophia, a leading ophthalmology company, discusses the significant growth of the Colombian affiliate to become an operational center for the Andean region. Additionally, he highlights their highly innovative product portfolio and ambitious plans to expand into new markets. When we interviewed your predecessor, Luz…

Indonesia Ashish D. Pal, President Director at MSD Indonesia, discusses the importance of introducing innovative pharmaceuticals, vaccines and biologics to address significant unmet needs and the strategic importance of the universal healthcare coverage program (JKN) towards meeting the national healthcare goals. Mr. Pal, you have been leading the Indonesian affiliate of…

Indonesia Agus Heru Darjono, President Director at Metro Drug Indonesia, highlights the opportunities in the Indonesian Third Party Commercialization sector and emphasizes the importance of building the best team in order to successfully perform in an ever-changing market like Indonesia. Can you briefly speak towards the history as well as the…

Colombia Héctor Castro, director of Medicines and Health Technologies at the Colombian Ministry of Health since 2016, explains how the regulations and quality standards implemented have contributed to make Colombia’s healthcare system one of the best in Latin America. You were appointed director of Medicines and Health Technologies at the Ministry…

Ukraine Tatyana Pechaeva, Managing Director of the Lekhim Group, one of Ukraine’s top ten domestic pharmaceutical companies, shares the main principles of her strategy which have enabled Lekhim to display high growth rates over recent years despite the country’s unstable economy. The Lekhim group of companies was one of the pioneers…

Indonesia Holger Welters, President Director at Beiersdorf Indonesia, discusses the ambitious growth plan for emerging markets that is propelling the company to new heights and sheds light on the importance of bringing high quality skincare solutions to Indonesia through Nivea® and Hansaplast®. Mr. Welters, you have been President Director of Beiersdorf’s…

Colombia Juan Gabriel Pérez, Executive Director of Invest in Bogota, shares his powerful message of why Bogota is an ideal investment destination, not only relative to other Colombian cities, but to Latin America as a whole. He speaks about the economic advantages of duty-free zones in the city, the untapped potential…

Indonesia Endang Hoyaranda, Commissioner and President Director at Prodia Group, elaborates on Prodia’s pioneering spirit when implementing its diversification business strategy and explains how the company has successfully completed its IPO process on the Indonesian stock exchange (IDX). Prodia recently completed its IPO in the Indonesian stock market (IDX) issuing 25…

Taiwan Weichyun Wong, president of SCI Pharmtech, discusses the API manufacturer’s transition from a Swiss-owned affiliate to a Taiwanese company. He also talks technology and regulatory challenges, as well as what differentiates SCI Pharmtech from its competitors. SCI Pharmtech, Inc. has a long-standing presence in Taiwan. Could you tell us a…

Hong Kong Jun Wang, founder and CEO of GeneHarbor Biotechnologies, introduces his company’s innovative technology platform and the specificities of the start-up ecosystem in Hong Kong. Dr. Wang, can you firstly tell us more about GeneHarbor’s innovative technology platform? What makes it so special? “I think that an original innovation company requires…

Taiwan Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision for the future growth of the company through partnerships with big pharmaceutical companies. Could you introduce yourself to our executive…